Quick Answer
Cellebrite DI Ltd. reported Diluted EPS of $0.31 per share for fiscal year 2025.
Cellebrite DI Ltd. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | $0.31 | +123.0% |
| 2024 | -$1.35 | -214.0% |
| 2023 | -$0.43 | -172.9% |
| 2022 | $0.59 | +34.1% |
| 2021 | $0.44 | +650.0% |
| 2020 | -$0.08 | +0.0% |
| 2019 | -$0.08 | — |
- Cellebrite DI Ltd. showed an increase of +123.0% in Diluted EPS compared to the prior fiscal year.
- Over the 2019–2025 period, Cellebrite DI Ltd.’s diluted eps has grown by 487.5% (from $0.08 per share (loss) to $0.31 per share).
- The most recent figure is from Cellebrite DI Ltd.’s fiscal year 2025 report (Form 20-F), filed with the SEC on March 3, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: